Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

Breast Cancer Research and Treatment

Volumn 118, Issue 1, 2009, Pages 131-137

  Nofech Mozes, Sharon ^a   Trudeau, Maureen ^b   Kahn, Harriet K ^a   Dent, Rebecca ^b   Rawlinson, Ellen ^b   Sun, Ping ^b   Narod, Steven A ^b   Hanna, Wedad M ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Basal like; Breast cancer; Metastases; Normal like; Prognosis; Triple negative

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER RECURRENCE; CELL PROLIFERATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL DIVISION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KERATIN-5; KERATIN-6; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 70349932822     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0295-8     Document Type: Article

References (22)

1. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10963602 (Pubitemid 30671230)
2. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 10.1073/pnas.0932692100 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D 12829800 (Pubitemid 36842560)
3. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874 10.1073/pnas.191367098 10.1073/pnas. 191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D 11553815 (Pubitemid 32878711)
4. V van' H Dai V Van d, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a 10.1038/415530a (Pubitemid 34130608)
5. V Van d YD He LJ van't Veer, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009 10.1056/NEJMoa021967 10.1056/NEJMoa021967 (Pubitemid 35461656)
6. O Fadare FA Tavassoli 2007 The phenotypic spectrum of basal-like breast cancers: a critical appraisal Adv Anat Pathol 14 5 358 373 10.1097/PAP. 0b013e31814b26fe 10.1097/PAP.0b013e31814b26fe 1:CAS:528:DC%2BD2sXhtVKgs73P 17717437 (Pubitemid 47312292)
7. TO Nielsen FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374 10.1158/1078-0432.CCR-04-0220 10.1158/1078-0432.CCR- 04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 15328174 (Pubitemid 39100473)
8. A Goldhirsch WC Wood RD Gelber, et al. 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer Ann Oncol 18 7 1133 1144 10.1093/annonc/mdm271 10.1093/annonc/mdm271 1:STN:280:DC%2BD2svlvVSkuw%3D%3D 17675394 (Pubitemid 47244357)
9. W Domagala J Lasota A Dukowicz, et al. 1990 Vimentin expression appears to be associated with poor prognosis in node negative ductal NOS breast carcinomas Am J Pathol 137 1299 1304 1:STN:280:DyaK3M%2Fot12jug%3D%3D 1701960
10. H Li P Cherukuri N Li V Cowling, et al. 2007 Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors Cancer Res 67 2 501 510 10.1158/0008-5472.CAN-05- 4571 10.1158/0008-5472.CAN-05-4571 1:CAS:528:DC%2BD2sXmtVKlsQ%3D%3D 17234757 (Pubitemid 46192186)
11. EA Rakha TC Putti DM bd El-Rehim, et al. 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 4 495 506 10.1002/path.1916 10.1002/path.1916 1:CAS:528:DC%2BD28XislCqt78%3D 16429394 (Pubitemid 43329336)
12. KA Hoadley VJ Weigman C Fan, et al. 2007 EGFR associated expression profiles vary with breast tumor subtype BMC Genomics 8 258 10.1186/1471-2164-8- 258 10.1186/1471-2164-8-258 17663798 (Pubitemid 47559211)
13. RM van de CM Perou R Tibshirani, et al. 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 6 1991 1996
14. EA Rakha DA El-Rehim C Paish, et al. 2006 Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 18 3149 3156 10.1016/j.ejca.2006.08.015 10.1016/j.ejca.2006.08.015 1:CAS:528:DC%2BD28Xht12rtrzK 17055256 (Pubitemid 44854512)
15. R Dent M Trudeau KI Pritchard, et al. 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 (15 Pt 1) 4429 4434 10.1158/1078-0432.CCR-06-3045 10.1158/1078-0432.CCR-06-3045 17671126 (Pubitemid 47219710)
16. J Gaedcke F Traub S Milde, et al. 2007 Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer Mod Pathol 20 8 864 870 10.1038/modpathol.3800830 10.1038/modpathol.3800830 1:CAS:528: DC%2BD2sXnvVeks7Y%3D 17541441 (Pubitemid 47077270)
17. D Palmieri QR Smith PR Lockman, et al. 2006 Brain metastases of breast cancer Breast Dis 26 139 147 1:CAS:528:DC%2BD2sXksVCjt7g%3D 17473372
18. Dent R, Hanna WM, Ttrudeau M, et al. (2008) Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat (in press)
19. CA Livasy G Karaca R Nanda, et al. 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 2 264 271 10.1038/modpathol.3800528 10.1038/modpathol.3800528 1:CAS:528: DC%2BD28Xlt1eqtw%3D%3D 16341146 (Pubitemid 43117611)
20. R Rouzier CM Perou WF Symmans, et al. 2005 Breast cancer molecular subtypes respond differently to pre-operative chemotherapy Clin Cancer Res 11 5678 5685 10.1158/1078-0432.CCR-04-2421 1:CAS:528:DC%2BD2MXos1Cjs7k%3D 16115903 (Pubitemid 41170290)
21. M Jumppanen S Gruvberger-Saal P Kauraniemi, et al. 2007 Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers Breast Cancer Res 9 1 R16 10.1186/bcr1649 10.1186/bcr1649 17263897 (Pubitemid 350215145)
22. B Kreike M van Kouwenhove H Horlings 2007 Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast Cancer Res 9 5 R65 10.1186/bcr1771 17910759 (Pubitemid 350187481)